Already using testosterone? What a planned transfer review would involve.

A transfer is not an automatic continuation. The clinician will independently review how the original diagnosis was made, how you have responded and whether continuing, adjusting or stopping treatment would be appropriate.

Continuation of a current prescription, dose or product is not promised. The review may support continuing care, a change, further testing or referral elsewhere.

Once secure intake is available, the practice will explain which records to request from your current prescriber. Useful information often includes:

• Laboratory results from before treatment started, including the time of day they were drawn.
• Recent monitoring results.
• The medication, dose, route and how long you have used it.
• Any side effects, other medications and other relevant conditions.
• Fertility plans and any previous fertility evaluation.

Do not send records through this website or ordinary email. There is no active record-transfer process during prelaunch.

Depending on your records, the clinician may need new laboratory results. Timing matters for people on treatment: results are usually interpreted in relation to when the last dose was taken. Testing requirements will be explained before you proceed.

If treatment began without well-documented testing, the clinician may discuss what can still be learned and what cannot.

Any prescription decision would be made only after the assessment. If care continues, the plan would describe follow-up timing, monitoring and how routine questions and medication requests are handled.

Because a gap in supply can matter, keep your current prescriber involved until a new plan has been agreed. The practice will not be able to provide bridging prescriptions during prelaunch.

The review may identify a reason to consider a different dose, product or approach, or to address another contributor such as sleep, weight or medications. If fertility is a priority, that may change the options discussed. Some situations will be better served by an endocrinologist, urologist or fertility specialist.

A transfer review is planned to follow the same structure as a new testosterone evaluation: a professional evaluation fee, with any laboratory testing as a separate cost consideration. How testing will be arranged and paid for remains under review.

The proposed ongoing TRT membership would apply only if you are accepted into ongoing care. Its fee and inclusions have not been approved. Psychiatric care is billed separately and is not part of any TRT arrangement.

Read the planned fee structure